35 Facts About Breast cancer

The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning tissue.

Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments are most likely to be effective.

In those in whom the Breast cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.

Outcomes for breast cancer vary depending on the cancer type, the extent of disease, and the person's age.

Inflammatory breast cancer is a rare yet aggressive form of breast cancer characterized by the swollen, red areas formed on the top of the breast.

Related searches

The visual effects of inflammatory breast cancer is a result of a blockage of lymph vessels by cancer cells.

Common symptoms of stage 4 Breast cancer include unexplained weight loss, bone and joint pain, jaundice and neurological symptoms.

Rarely breast cancer can spread to exceedingly uncommon sites such as peripancreatic lymph nodes causing biliary obstruction leading to diagnostic difficulties.

Mutations that can lead to breast cancer have been experimentally linked to estrogen exposure.

Breast cancer screening refers to testing otherwise-healthy women for breast cancer in an attempt to achieve an earlier diagnosis under the assumption that early detection will improve outcomes.

Mammographic screening for breast cancer uses X-rays to examine the breast for any uncharacteristic masses or lumps.

Women can reduce their risk of breast cancer by maintaining a healthy weight, reducing alcohol use, increasing physical activity, and breast-feeding.

The benefit of breast cancer reduction continues for at least five years after stopping a course of treatment with these medications.

Management of breast cancer depends on various factors, including the stage of the cancer and the person's age.

Treatments are more aggressive when the Breast cancer is more advanced or there is a higher risk of recurrence of the Breast cancer following treatment.

Tamoxifen increases the risk of postmenopausal bleeding, endometrial polyps, hyperplasia, and endometrial Breast cancer; using tamoxifen with an intrauterine system releasing levonorgestrel might increase vaginal bleeding after 1 to 2 years, but reduces somewhat endometrial polyps and hyperplasia, but not necessarily endometrial Breast cancer.

Stage of the breast cancer is the most important component of traditional classification methods of breast cancer, because it has a greater effect on the prognosis than the other considerations.

Breast cancer grade is assessed by comparison of the breast cancer cells to normal breast cells.

The closer to normal the Breast cancer cells are, the slower their growth and the better the prognosis.

Premenopausal women with estrogen-receptor positive breast cancer must confront the issues of early menopause induced by many of the chemotherapy regimens used to treat their breast cancer, especially those that use hormones to counteract ovarian function.

Breast cancer could be felt through the skin, and in its advanced state often developed into fungating lesions: the tumor would become necrotic and ulcerate through the skin, weeping fetid, dark fluid.

Oldest discovered evidence of breast cancer is from Egypt and dates back 4200 years, to the Sixth Dynasty.

Ancient medicine, from the time of the Greeks through the 17th century, was based on humoralism, and thus believed that breast cancer was generally caused by imbalances in the fundamental fluids that controlled the body, especially an excess of black bile.

Mastectomy for breast cancer was performed at least as early as AD 548, when it was proposed by the court physician Aetios of Amida to Theodora.

Each failing treatment for breast cancer led to the search for new treatments, spurring a market in remedies that were advertised and sold by quacks, herbalists, chemists and apothecaries.

Related searches

Breast cancer was uncommon until the 19th century, when improvements in sanitation and control of deadly infectious diseases resulted in dramatic increases in lifespan.

Breast cancer staging systems were developed in the 1920s and 1930s to determining the extent to which a cancer has developed by growing and spreading.

The first case-controlled study on breast cancer epidemiology was done by Janet Lane-Claypon, who published a comparative study in 1926 of 500 breast cancer cases and 500 controls of the same background and lifestyle for the British Ministry of Health.

In 2009 the US science journalist Christie Aschwanden criticized that the emphasis on breast cancer screening may be harming women by subjecting them to unnecessary radiation, biopsies, and surgery.

Breast cancer is the most prevalent cancer affecting women of every ethnic group in the United States.

Breast cancer treatment has improved greatly in recent years, but black women are still less likely to obtain treatment compared to white women.

Socioeconomic determinants affecting the disparity in breast cancer illness include poverty, culture, as well as social injustice.

Low-income women are less likely to undergo breast cancer screening and thus are more likely to have a late-stage diagnosis.

Breast cancer then becomes more common in the 5 or 10 years following pregnancy but then becomes less common than among the general population.

Clinically, the most useful metabolic markers in breast cancer are the estrogen and progesterone receptors that are used to predict response to hormone therapy.